世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

脳神経外科に関する市場調査。脳神経外科用インターベンションデバイスの需要は最も高い水準で推移


Market Study on Neurosurgery: Demand to Remain Highest for Neuro-interventional Devices

脳神経外科市場レポート対象範囲 世界の脳神経外科市場に関するPersistence Market Researchの最新出版物は、機会と現在の市場ランドスケープを評価し、市場に影響を与える対応するセクションについての詳細な... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Persistence Market Research
パーシスタンスマーケットリサーチ
2022年8月5日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
300 英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

脳神経外科市場レポート対象範囲

世界の脳神経外科市場に関するPersistence Market Researchの最新出版物は、機会と現在の市場ランドスケープを評価し、市場に影響を与える対応するセクションについての詳細な分析と更新を提供します。この研究は、市場のドライバー、抑制、トレンド、および機会を含む現在の市場ダイナミクスに詳細な洞察を提供しています。市場調査の主な目的は、市場が2022年から2032年の予測期間中に実行される方法についての排他的な情報を提示することです。

市場の成功成長のための重要な指標は、この包括的なレポートで提示されており、市場の前年比(YoY)成長分析、複合年間成長率(CAGR)など、Persistence Market Research社の調査において網羅的に記述されています。この調査研究は、脳神経外科市場製品の需要と調査期間中の定量的な開発機会を知るために読者をサポートすることができます。

この研究は、投資家、メーカー、サービスプロバイダー、流通業者、サプライヤーなどの景観の株主にとって有益であり、脳神経外科市場で繁栄するために適切なビジネス戦略を開発する際にそれらを助けることができますこのPersistence Market Researchの研究で示された洞察と情報は、脳神経外科市場の株主、業界の専門家、投資家、研究者および記者、ならびにビジネス愛好家によって活用されることができる。

市場統計だけでなく、神経外科市場のビジネスシナリオに影響を与えるマクロだけでなく、ミクロ経済変数にリンクされている情報は、現在の研究にも含まれています。市場の潜在的な開発に応じて、実質的な洞察力は、このレポートで発生します。さらに、このレポートで提出されたデータによって、マイナーな企業や業界の新規参入者は、市場での牽引力を達成するために適切な企業の選択を行う際に支援することができます。

主要な市場セグメント

Persistence Market Researchの脳神経外科市場に関する調査では、製品、エンドユーザー、地域の3つの重要なセグメントに分けられた情報を提供しています。本レポートでは、これらのカテゴリに関連する重要な市場ダイナミクスと成長パラメータに関する包括的なデータと情報を提供しています。

製品

神経インターベンションデバイス
神経血管塞栓用デバイス
塞栓用コイル
リキッドエンボリックシステム
フローダイバージョンステント
動脈瘤クリップ
脳血管内コイリングアシスト装置
コイリングアシストステント
コイリングアシストバルーン
血管内血栓除去装置
ステントリトリーバー
吸引式リトリーバー
マイクロガイドワイヤー
マイクロカテーテル
サポートカテーテル
頭蓋内ステント
神経内視鏡
軟性神経内視鏡
硬性神経内視鏡
脳外科用ドリル
空気圧式脳外科手術用ドリル
電気式脳外科手術用ドリル
放射線手術装置
リニアアクセラレータ放射線手術システム
ガンマナイフ放射線手術システム
硬膜代替物
生体硬膜代替物
合成硬膜代替物
脳神経外科用アブレーションデバイス
MRIガイド下集束超音波装置
MRIガイド下レーザー治療装置
MRIガイド下RFアブレーションシステム
脳神経外科手術用器具
ティッシュリトラクター
鉗子
ヘッドフレーム
頚椎固定装置
パーフォレーター
エンドユーザー

病院
外来外科センター
神経系専門施設
地域別

北アメリカ
ラテンアメリカ
欧州
東アジア
南アジア
オセアニア
中東・アフリカ
報告書に記載されている主な質問

今後数年間、脳神経外科の最も収益性の高い市場として存続し続けるのはどの地域か?
トレンドの変化は市場にどのような影響を与えるか?
COVID-19危機は市場の成長にどのような影響を及ぼしたか?
市場参加者はどのようにして先進地域の低空飛行の機会を捉えることができるのか?
市場におけるステークホルダーの戦略はどのようなものですか?
投資家が認識する必要があり、市場への投資中に取り組む可能性がある抑制要因は何か?
市場に影響を与える開発動向は何か?
脳神経外科市場の企業は、どのようにして先進国および新興国の成長機会を利用することができるのか?
調査方法

Persistence Market Research社の調査では、神経外科市場の成長に関する広範な調査を実施し、市場の将来の成長パラメータに関する結論に到達するために、独自の調査手法が利用されている。この調査手法は、一次調査と二次調査を組み合わせたもので、アナリストが結論の正確性と信頼性を確保するのに役立つものである。

市場調査作成時にアナリストが参照した二次資料には、政府機関の統計、業界誌、ホワイトペーパー、社内外の独自データベースなどがあります。アナリストは一次資料として、本レポートの作成に貢献したシニアマネージャー、製品ポートフォリオマネージャー、CEO、副社長、マーケティング/プロダクトマネージャー、マーケットインテリジェンスマネージャーにインタビューを行いました。

一次および二次リソースから取得した包括的な情報は、市場の企業からの検証として機能し、神経外科市場の成長見通しに関するPersistence Market Researchの予測をより正確かつ信頼性の高いものにしています。

ページTOPに戻る


目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions & Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Key Disease Epidemiology

4.2. Product Adoption / Usage Analysis

4.3. Product USPs / Features

4.4. Key Promotional Strategies, By Manufacturers

4.5. Porter’s Analysis

4.6. PESTLE Analysis

4.7. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global Healthcare Market GDP and Growth Outlook

5.1.2. Global Assistive Devices Market Overview

5.1.3. Medical Device Industry Overview

5.2. Forecast Factors - Relevance & Impact

5.2.1. GDP Growth Forecast

5.2.2. Ageing Population

5.2.3. Growing Prevalence of Neurologic Diseases

5.2.4. Growing Healthcare Expenditure

5.2.5. Shift Towards Minimally Invasive Procedures

5.2.6. Growing Research Efforts

5.2.7. Cost Impact

5.2.8. Entries Of New Start-Up Companies In The Market

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis

6.1.1. Revenue By Product

6.1.2. Revenue By End User

6.1.3. Revenue by Country

6.2. 2021 Market Scenario

7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022–2032

7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By Product

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2021

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022–2032

8.3.1. Neuro Interventional Devices

8.3.1.1. Neurovascular Embolization Devices

8.3.1.1.1. Embolization Coils

8.3.1.1.2. Liquid Embolic Systems

8.3.1.1.3. Flow Diversion Stents

8.3.1.1.4. Aneurysm Clips

8.3.1.2. Neurovascular Coiling Assist Devices

8.3.1.2.1. Coiling Assist Stents

8.3.1.2.2. Coiling Assist Balloons

8.3.1.3. Neurovascular Thrombectomy Devices

8.3.1.3.1. Stent Retrievers

8.3.1.3.2. Aspiration Retrievers

8.3.1.4. Microguidewires

8.3.1.5. Microcatheters

8.3.1.6. Support Catheters

8.3.1.7. Intracranial Stents

8.3.2. Neuroendoscopes

8.3.2.1. Flexible Neuroendoscopes

8.3.2.2. Rigid Neuroendoscopes

8.3.3. Neurosurgical Drills

8.3.3.1. Pneumatic Neurosurgical Drills

8.3.3.2. Electrical Neurosurgical Drills

8.3.4. Radiosurgery Systems

8.3.4.1. Linear Accelerator Radiosurgery Systems

8.3.4.2. Gamma Knife Radiosurgery Systems

8.3.5. Dura Substitutes

8.3.5.1. Biological Dura Substitutes

8.3.5.2. Synthetic Dura Substitutes

8.3.6. Neurosurgical Ablation Devices

8.3.6.1. MRI Guided Focused Ultrasound Systems

8.3.6.2. MRI Guided Laser Therapy Systems

8.3.6.3. MRI Guided RF Ablation Systems

8.3.7. Neurosurgery Instruments

8.3.7.1. Tissue Retractors

8.3.7.2. Forceps

8.3.7.3. Head Frames

8.3.7.4. Cervical Plating systems

8.3.7.5. Perforators

8.4. Market Attractiveness Analysis By Product

9. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By End User

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

9.3.1. Hospitals

9.3.2. Ambulatory Surgical Centers

9.3.3. Specialized Neurological Institutes

9.4. Market Attractiveness Analysis By End User

10. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, by Region

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

10.3.1. North America

10.3.2. Latin America

10.3.3. Europe

10.3.4. East Asia

10.3.5. South Asia

10.3.6. Oceania

10.3.7. Middle East and Africa (MEA)

10.4. Market Attractiveness Analysis By Region

11. North America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

11.3.1. By Country

11.3.1.1. U.S.

11.3.1.2. Canada

11.3.2. By Product

11.3.3. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Product

11.4.3. By End User

11.5. Market Trends

11.6. Key Market Participants - Intensity Mapping

11.7. Drivers and Restraints - Impact Analysis

11.8. Country Level Analysis & Forecast

11.8.1. U.S. Neurosurgery Market

11.8.1.1. Introduction

11.8.1.2. Market Analysis and Forecast by Market Taxonomy

11.8.1.2.1. By Product

11.8.1.2.2. By End User

11.8.2. Canada Neurosurgery Market

11.8.2.1. Introduction

11.8.2.2. Market Analysis and Forecast by Market Taxonomy

11.8.2.2.1. By Product

11.8.2.2.2. By End User

12. Latin America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

12.3.1. By Country

12.3.1.1. Brazil

12.3.1.2. Argentina

12.3.1.3. Mexico

12.3.1.4. Rest of Latin America

12.3.2. By Product

12.3.3. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Product

12.4.3. By End User

12.5. Market Trends

12.6. Key Market Participants - Intensity Mapping

12.7. Drivers and Restraints - Impact Analysis

12.8. Country Level Analysis & Forecast

12.8.1. Brazil Neurosurgery Market

12.8.1.1. Introduction

12.8.1.2. Market Analysis and Forecast by Market Taxonomy

12.8.1.2.1. By Product

12.8.1.2.2. By End User

12.8.2. Mexico Neurosurgery Market

12.8.2.1. Introduction

12.8.2.2. Market Analysis and Forecast by Market Taxonomy

12.8.2.2.1. By Product

12.8.2.2.2. By End User

12.8.3. Argentina Neurosurgery Market

12.8.3.1. Introduction

12.8.3.2. Market Analysis and Forecast by Market Taxonomy

12.8.3.2.1. By Product

12.8.3.2.2. By End User

13. Europe Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. France

13.3.1.3. Italy

13.3.1.4. Spain

13.3.1.5. UK

13.3.1.6. BENELUX

13.3.1.7. Russia

13.3.1.8. Nordic Countries

13.3.1.9. Rest of Europe

13.3.2. By Product

13.3.3. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product

13.4.3. By End User

13.5. Market Trends

13.6. Key Market Participants - Intensity Mapping

13.7. Drivers and Restraints - Impact Analysis

13.8. Country Level Analysis & Forecast

13.8.1. Germany Neurosurgery Market

13.8.1.1. Introduction

13.8.1.2. Market Analysis and Forecast by Market Taxonomy

13.8.1.2.1. By Product

13.8.1.2.2. By End User

13.8.2. Italy Neurosurgery Market

13.8.2.1. Introduction

13.8.2.2. Market Analysis and Forecast by Market Taxonomy

13.8.2.2.1. By Product

13.8.2.2.2. By End User

13.8.3. France Neurosurgery Market

13.8.3.1. Introduction

13.8.3.2. Market Analysis and Forecast by Market Taxonomy

13.8.3.2.1. By Product

13.8.3.2.2. By End User

13.8.3.2.3.

13.8.4. Spain Neurosurgery Market

13.8.4.1. Introduction

13.8.4.2. Market Analysis and Forecast by Market Taxonomy

13.8.4.2.1. By Product

13.8.4.2.2. By End User

13.8.5. U.K. Neurosurgery Market

13.8.5.1. Introduction

13.8.5.2. Market Analysis and Forecast by Market Taxonomy

13.8.5.2.1. By Product

13.8.5.2.2. By End User

13.8.6. Benelux Union Neurosurgery Market

13.8.6.1. Introduction

13.8.6.2. Market Analysis and Forecast by Market Taxonomy

13.8.6.2.1. By Product

13.8.6.2.2. By End User

13.8.7. Nordic Countries Neurosurgery Market

13.8.7.1. Introduction

13.8.7.2. Market Analysis and Forecast by Market Taxonomy

13.8.7.2.1. By Product

13.8.7.2.2. By End User

13.8.8. Russia Neurosurgery Market

13.8.8.1. Introduction

13.8.8.2. Market Analysis and Forecast by Market Taxonomy

13.8.8.2.1. By Product

13.8.8.2.2. By End User

14. South Asia and Pacific Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

14.3.1. By Country

14.3.1.1. India

14.3.1.2. Indonesia

14.3.1.3. Malaysia

14.3.1.4. Thailand

14.3.1.5. Rest of South Asia

14.3.2. By Product

14.3.3. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product

14.4.3. By End User

14.5. Market Trends

14.6. Key Market Participants - Intensity Mapping

14.7. Drivers and Restraints - Impact Analysis

14.8. Country Level Analysis & Forecast

14.8.1. India Neurosurgery Market

14.8.1.1. Introduction

14.8.1.2. Market Analysis and Forecast by Market Taxonomy

14.8.1.2.1. By Product

14.8.1.2.2. By End User

14.8.2. Indonesia Neurosurgery Market

14.8.2.1. Introduction

14.8.2.2. Market Analysis and Forecast by Market Taxonomy

14.8.2.2.1. By Product

14.8.2.2.2. By End User

14.8.3. Malaysia Neurosurgery Market

14.8.3.1. Introduction

14.8.3.2. Market Analysis and Forecast by Market Taxonomy

14.8.3.2.1. By Product

14.8.3.2.2. By End User

14.8.4. Thailand Neurosurgery Market

14.8.4.1. Introduction

14.8.4.2. Market Analysis and Forecast by Market Taxonomy

14.8.4.2.1. By Product

14.8.4.2.2. By End User

15. East Asia Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

15.3.1. By Country

15.3.1.1. China

15.3.1.2. Japan

15.3.1.3. South Korea

15.3.2. By Product

15.3.3. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product

15.4.3. By End User

15.5. Market Trends

15.6. Key Market Participants - Intensity Mapping

15.7. Drivers and Restraints - Impact Analysis

15.8. Country Level Analysis & Forecast

15.8.1. China Neurosurgery Market

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. By Product

15.8.1.2.2. By End User

15.8.2. Japan Neurosurgery Market

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. By Product

15.8.2.2.2. By End User

15.8.3. South Korea Neurosurgery Market

15.8.3.1. Introduction

15.8.3.2. Market Analysis and Forecast by Market Taxonomy

15.8.3.2.1. By Product

15.8.3.2.2. By End User

16. Oceania Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

16.3.1. By Country

16.3.1.1. Australia

16.3.1.2. New Zealand

16.3.2. By Product

16.3.3. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product

16.4.3. By End User

16.5. Market Trends

16.6. Key Market Participants - Intensity Mapping

16.7. Drivers and Restraints - Impact Analysis

16.8. Country Level Analysis & Forecast

16.8.1. Australia Neurosurgery Market

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. By Product

16.8.1.2.2. By End User

16.8.2. New Zealand Neurosurgery Market

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. By Product

16.8.2.2.2. By End User

17. Middle East and Africa Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

17.3.1. By Country

17.3.1.1. GCC Countries

17.3.1.2. Turkey

17.3.1.3. Israel

17.3.1.4. Northern Africa

17.3.1.5. South Africa

17.3.1.6. Rest of Middle East and Africa

17.3.2. By Product

17.3.3. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product

17.4.3. By End User

17.5. Market Trends

17.6. Key Market Participants - Intensity Mapping

17.7. Drivers and Restraints - Impact Analysis

17.8. Country Level Analysis & Forecast

17.8.1. GCC Countries Neurosurgery Market

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. By Product

17.8.1.2.2. By End User

17.8.2. Turkey Neurosurgery Market

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. By Product

17.8.2.2.2. By End User

17.8.3. North Africa Neurosurgery Market

17.8.3.1. Introduction

17.8.3.2. Market Analysis and Forecast by Market Taxonomy

17.8.3.2.1. By Product

17.8.3.2.2. By End User

17.8.4. South Africa Neurosurgery Market

17.8.4.1. Introduction

17.8.4.2. Market Analysis and Forecast by Market Taxonomy

17.8.4.2.1. By Product

17.8.4.2.2. By End User

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies

18.2. Market Share Analysis of Top Players

18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard

19.2. Competition Benchmarking

19.3. Competition Deep Dive

19.3.1. Stryker Corp.

19.3.1.1. .Overview

19.3.1.2. Product Portfolio

19.3.1.3. Key Financials

19.3.1.4. SWOT Analysis

19.3.1.5. Key Developments

19.3.1.6. Sales Footprint

19.3.1.7. Strategy Overview

19.3.1.7.1. Marketing Strategy

19.3.1.7.2. Product Strategy

19.3.1.7.3. Channel Strategy

19.3.2. B. Braun Melsungen AG

19.3.2.1. Overview

19.3.2.2. Product Portfolio

19.3.2.3. Key Financials

19.3.2.4. SWOT Analysis

19.3.2.5. Key Developments

19.3.2.6. Sales Footprint

19.3.2.7. Strategy Overview

19.3.2.7.1. Marketing Strategy

19.3.2.7.2. Product Strategy

19.3.2.7.3. Channel Strategy

19.3.3. Medtronic plc

19.3.3.1. Overview

19.3.3.2. Product Portfolio

19.3.3.3. Key Financials

19.3.3.4. SWOT Analysis

19.3.3.5. Key Developments

19.3.3.6. Sales Footprint

19.3.3.7. Strategy Overview

19.3.3.7.1. Marketing Strategy

19.3.3.7.2. Product Strategy

19.3.3.7.3. Channel Strategy

19.3.4. DePuy Synthes

19.3.4.1. Overview

19.3.4.2. Product Portfolio

19.3.4.3. Key Financials

19.3.4.4. SWOT Analysis

19.3.4.5. Key Developments

19.3.4.6. Sales Footprint

19.3.4.7. Strategy Overview

19.3.4.7.1. Marketing Strategy

19.3.4.7.2. Product Strategy

19.3.4.7.3. Channel Strategy

19.3.5. Boston Scientific

19.3.5.1. Overview

19.3.5.2. Product Portfolio

19.3.5.3. Key Financials

19.3.5.4. SWOT Analysis

19.3.5.5. Key Developments

19.3.5.6. Sales Footprint

19.3.5.7. Strategy Overview

19.3.5.7.1. Marketing Strategy

19.3.5.7.2. Product Strategy

19.3.5.7.3. Channel Strategy

19.3.6. Terumo Corporation

19.3.6.1. Overview

19.3.6.2. Product Portfolio

19.3.6.3. Key Financials

19.3.6.4. SWOT Analysis

19.3.6.5. Key Developments

19.3.6.6. Sales Footprint

19.3.6.7. Strategy Overview

19.3.6.7.1. Marketing Strategy

19.3.6.7.2. Product Strategy

19.3.6.7.3. Channel Strategy

19.3.7. KARL STORZ GmbH & Co KG

19.3.7.1. Overview

19.3.7.2. Product Portfolio

19.3.7.3. Key Financials

19.3.7.4. SWOT Analysis

19.3.7.5. Key Developments

19.3.7.6. Sales Footprint

19.3.7.7. Strategy Overview

19.3.7.7.1. Marketing Strategy

19.3.7.7.2. Product Strategy

19.3.7.7.3. Channel Strategy

19.3.8. Integra LifeSciences

19.3.8.1. Overview

19.3.8.2. Product Portfolio

19.3.8.3. Key Financials

19.3.8.4. SWOT Analysis

19.3.8.5. Key Developments

19.3.8.6. Sales Footprint

19.3.8.7. Strategy Overview

19.3.8.7.1. Marketing Strategy

19.3.8.7.2. Product Strategy

19.3.8.7.3. Channel Strategy

19.3.9. Penumbra Inc

19.3.9.1. Overview

19.3.9.2. Product Portfolio

19.3.9.3. Key Financials

19.3.9.4. SWOT Analysis

19.3.9.5. Key Developments

19.3.9.6. Sales Footprint

19.3.9.7. Strategy Overview

19.3.9.7.1. Marketing Strategy

19.3.9.7.2. Product Strategy

19.3.9.7.3. Channel Strategy

19.3.10. Adeor Medical AG

19.3.10.1. Overview

19.3.10.2. Product Portfolio

19.3.10.3. Key Financials

19.3.10.4. SWOT Analysis

19.3.10.5. Key Developments

19.3.10.6. Sales Footprint

19.3.10.7. Strategy Overview

19.3.10.7.1. Marketing Strategy

19.3.10.7.2. Product Strategy

19.3.10.7.3. Channel Strategy

19.3.11. Elekta

19.3.11.1. Overview

19.3.11.2. Product Portfolio

19.3.11.3. Key Financials

19.3.11.4. SWOT Analysis

19.3.11.5. Key Developments

19.3.11.6. Sales Footprint

19.3.11.7. Strategy Overview

19.3.11.7.1. Marketing Strategy

19.3.11.7.2. Product Strategy

19.3.11.7.3. Channel Strategy

19.3.12. Clarus Medical

19.3.12.1. Overview

19.3.12.2. Product Portfolio

19.3.12.3. Key Financials

19.3.12.4. SWOT Analysis

19.3.12.5. Key Developments

19.3.12.6. Sales Footprint

19.3.12.7. Strategy Overview

19.3.12.7.1. Marketing Strategy

19.3.12.7.2. Product Strategy

19.3.12.7.3. Channel Strategy

19.3.13. MACHIDA ENDOSCOPE CO., LTD.

19.3.13.1. Overview

19.3.13.2. Product Portfolio

19.3.13.3. Key Financials

19.3.13.4. SWOT Analysis

19.3.13.5. Key Developments

19.3.13.6. Sales Footprint

19.3.13.7. Strategy Overview

19.3.13.7.1. Marketing Strategy

19.3.13.7.2. Product Strategy

19.3.13.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

 

ページTOPに戻る


 

Summary

Neurosurgery Market: Scope of Report

The latest publication by Persistence Market Research on the global neurosurgery market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2022-2032.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for neurosurgery market products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the neurosurgery market insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the neurosurgery market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the neurosurgery market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the neurosurgery market offers information divided into three important segments – product, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product

Neuro Interventional Devices
Neurovascular Embolization Devices
Embolization Coils
Liquid Embolic Systems
Flow Diversion Stents
Aneurysm Clips
Neurovascular Coiling Assist Devices
Coiling Assist Stents
Coiling Assist Balloons
Neurovascular Thrombectomy Devices
Stent Retrievers
Aspiration Retrievers
Microguidewires
Microcatheters
Support Catheters
Intracranial Stents
Neuroendoscopes
Flexible Neuroendoscopes
Rigid Neuroendoscopes
Neurosurgical Drills
Pneumatic Neurosurgical Drills
Electrical Neurosurgical Drills
Radiosurgery Systems
Linear Accelerator Radiosurgery Systems
Gamma Knife Radiosurgery Systems
Dura Substitutes
Biological Dura Substitutes
Synthetic Dura Substitutes
Neurosurgical Ablation Devices
MRI Guided Focused Ultrasound Systems
MRI Guided Laser Therapy Systems
MRI Guided RF Ablation Systems
Neurosurgery Instruments
Tissue Retractors
Forceps
Head Frames
Cervical Plating systems
Perforators
End User

Hospitals
Ambulatory Surgical Centers
Specialized Neurological Institutes
Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa
Key Questions Answered in Report

Which regions will continue to remain the most profitable markets for neurosurgery over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the neurosurgery market avail themselves of the growth opportunities in developed and emerging sectors?
Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the neurosurgery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research’s projections on the growth prospects of the neurosurgery market more accurate and reliable.



ページTOPに戻る


Table of Contents

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply-Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions & Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Key Disease Epidemiology

4.2. Product Adoption / Usage Analysis

4.3. Product USPs / Features

4.4. Key Promotional Strategies, By Manufacturers

4.5. Porter’s Analysis

4.6. PESTLE Analysis

4.7. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global Healthcare Market GDP and Growth Outlook

5.1.2. Global Assistive Devices Market Overview

5.1.3. Medical Device Industry Overview

5.2. Forecast Factors - Relevance & Impact

5.2.1. GDP Growth Forecast

5.2.2. Ageing Population

5.2.3. Growing Prevalence of Neurologic Diseases

5.2.4. Growing Healthcare Expenditure

5.2.5. Shift Towards Minimally Invasive Procedures

5.2.6. Growing Research Efforts

5.2.7. Cost Impact

5.2.8. Entries Of New Start-Up Companies In The Market

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis

6.1.1. Revenue By Product

6.1.2. Revenue By End User

6.1.3. Revenue by Country

6.2. 2021 Market Scenario

7. Global Neurosurgery Market Demand (in Value or Size (US$ Mn) Analysis 2017-2021 and Forecast, 2022–2032

7.1. Historical Market Value (US$ Mn) Analysis, 2017–2021

7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By Product

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Product, 2017–2021

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2022–2032

8.3.1. Neuro Interventional Devices

8.3.1.1. Neurovascular Embolization Devices

8.3.1.1.1. Embolization Coils

8.3.1.1.2. Liquid Embolic Systems

8.3.1.1.3. Flow Diversion Stents

8.3.1.1.4. Aneurysm Clips

8.3.1.2. Neurovascular Coiling Assist Devices

8.3.1.2.1. Coiling Assist Stents

8.3.1.2.2. Coiling Assist Balloons

8.3.1.3. Neurovascular Thrombectomy Devices

8.3.1.3.1. Stent Retrievers

8.3.1.3.2. Aspiration Retrievers

8.3.1.4. Microguidewires

8.3.1.5. Microcatheters

8.3.1.6. Support Catheters

8.3.1.7. Intracranial Stents

8.3.2. Neuroendoscopes

8.3.2.1. Flexible Neuroendoscopes

8.3.2.2. Rigid Neuroendoscopes

8.3.3. Neurosurgical Drills

8.3.3.1. Pneumatic Neurosurgical Drills

8.3.3.2. Electrical Neurosurgical Drills

8.3.4. Radiosurgery Systems

8.3.4.1. Linear Accelerator Radiosurgery Systems

8.3.4.2. Gamma Knife Radiosurgery Systems

8.3.5. Dura Substitutes

8.3.5.1. Biological Dura Substitutes

8.3.5.2. Synthetic Dura Substitutes

8.3.6. Neurosurgical Ablation Devices

8.3.6.1. MRI Guided Focused Ultrasound Systems

8.3.6.2. MRI Guided Laser Therapy Systems

8.3.6.3. MRI Guided RF Ablation Systems

8.3.7. Neurosurgery Instruments

8.3.7.1. Tissue Retractors

8.3.7.2. Forceps

8.3.7.3. Head Frames

8.3.7.4. Cervical Plating systems

8.3.7.5. Perforators

8.4. Market Attractiveness Analysis By Product

9. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, By End User

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2021

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

9.3.1. Hospitals

9.3.2. Ambulatory Surgical Centers

9.3.3. Specialized Neurological Institutes

9.4. Market Attractiveness Analysis By End User

10. Global Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032, by Region

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By Region, 2017–2021

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

10.3.1. North America

10.3.2. Latin America

10.3.3. Europe

10.3.4. East Asia

10.3.5. South Asia

10.3.6. Oceania

10.3.7. Middle East and Africa (MEA)

10.4. Market Attractiveness Analysis By Region

11. North America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

11.3.1. By Country

11.3.1.1. U.S.

11.3.1.2. Canada

11.3.2. By Product

11.3.3. By End User

11.4. Market Attractiveness Analysis

11.4.1. By Country

11.4.2. By Product

11.4.3. By End User

11.5. Market Trends

11.6. Key Market Participants - Intensity Mapping

11.7. Drivers and Restraints - Impact Analysis

11.8. Country Level Analysis & Forecast

11.8.1. U.S. Neurosurgery Market

11.8.1.1. Introduction

11.8.1.2. Market Analysis and Forecast by Market Taxonomy

11.8.1.2.1. By Product

11.8.1.2.2. By End User

11.8.2. Canada Neurosurgery Market

11.8.2.1. Introduction

11.8.2.2. Market Analysis and Forecast by Market Taxonomy

11.8.2.2.1. By Product

11.8.2.2.2. By End User

12. Latin America Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

12.3.1. By Country

12.3.1.1. Brazil

12.3.1.2. Argentina

12.3.1.3. Mexico

12.3.1.4. Rest of Latin America

12.3.2. By Product

12.3.3. By End User

12.4. Market Attractiveness Analysis

12.4.1. By Country

12.4.2. By Product

12.4.3. By End User

12.5. Market Trends

12.6. Key Market Participants - Intensity Mapping

12.7. Drivers and Restraints - Impact Analysis

12.8. Country Level Analysis & Forecast

12.8.1. Brazil Neurosurgery Market

12.8.1.1. Introduction

12.8.1.2. Market Analysis and Forecast by Market Taxonomy

12.8.1.2.1. By Product

12.8.1.2.2. By End User

12.8.2. Mexico Neurosurgery Market

12.8.2.1. Introduction

12.8.2.2. Market Analysis and Forecast by Market Taxonomy

12.8.2.2.1. By Product

12.8.2.2.2. By End User

12.8.3. Argentina Neurosurgery Market

12.8.3.1. Introduction

12.8.3.2. Market Analysis and Forecast by Market Taxonomy

12.8.3.2.1. By Product

12.8.3.2.2. By End User

13. Europe Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

13.3.1. By Country

13.3.1.1. Germany

13.3.1.2. France

13.3.1.3. Italy

13.3.1.4. Spain

13.3.1.5. UK

13.3.1.6. BENELUX

13.3.1.7. Russia

13.3.1.8. Nordic Countries

13.3.1.9. Rest of Europe

13.3.2. By Product

13.3.3. By End User

13.4. Market Attractiveness Analysis

13.4.1. By Country

13.4.2. By Product

13.4.3. By End User

13.5. Market Trends

13.6. Key Market Participants - Intensity Mapping

13.7. Drivers and Restraints - Impact Analysis

13.8. Country Level Analysis & Forecast

13.8.1. Germany Neurosurgery Market

13.8.1.1. Introduction

13.8.1.2. Market Analysis and Forecast by Market Taxonomy

13.8.1.2.1. By Product

13.8.1.2.2. By End User

13.8.2. Italy Neurosurgery Market

13.8.2.1. Introduction

13.8.2.2. Market Analysis and Forecast by Market Taxonomy

13.8.2.2.1. By Product

13.8.2.2.2. By End User

13.8.3. France Neurosurgery Market

13.8.3.1. Introduction

13.8.3.2. Market Analysis and Forecast by Market Taxonomy

13.8.3.2.1. By Product

13.8.3.2.2. By End User

13.8.3.2.3.

13.8.4. Spain Neurosurgery Market

13.8.4.1. Introduction

13.8.4.2. Market Analysis and Forecast by Market Taxonomy

13.8.4.2.1. By Product

13.8.4.2.2. By End User

13.8.5. U.K. Neurosurgery Market

13.8.5.1. Introduction

13.8.5.2. Market Analysis and Forecast by Market Taxonomy

13.8.5.2.1. By Product

13.8.5.2.2. By End User

13.8.6. Benelux Union Neurosurgery Market

13.8.6.1. Introduction

13.8.6.2. Market Analysis and Forecast by Market Taxonomy

13.8.6.2.1. By Product

13.8.6.2.2. By End User

13.8.7. Nordic Countries Neurosurgery Market

13.8.7.1. Introduction

13.8.7.2. Market Analysis and Forecast by Market Taxonomy

13.8.7.2.1. By Product

13.8.7.2.2. By End User

13.8.8. Russia Neurosurgery Market

13.8.8.1. Introduction

13.8.8.2. Market Analysis and Forecast by Market Taxonomy

13.8.8.2.1. By Product

13.8.8.2.2. By End User

14. South Asia and Pacific Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

14.3.1. By Country

14.3.1.1. India

14.3.1.2. Indonesia

14.3.1.3. Malaysia

14.3.1.4. Thailand

14.3.1.5. Rest of South Asia

14.3.2. By Product

14.3.3. By End User

14.4. Market Attractiveness Analysis

14.4.1. By Country

14.4.2. By Product

14.4.3. By End User

14.5. Market Trends

14.6. Key Market Participants - Intensity Mapping

14.7. Drivers and Restraints - Impact Analysis

14.8. Country Level Analysis & Forecast

14.8.1. India Neurosurgery Market

14.8.1.1. Introduction

14.8.1.2. Market Analysis and Forecast by Market Taxonomy

14.8.1.2.1. By Product

14.8.1.2.2. By End User

14.8.2. Indonesia Neurosurgery Market

14.8.2.1. Introduction

14.8.2.2. Market Analysis and Forecast by Market Taxonomy

14.8.2.2.1. By Product

14.8.2.2.2. By End User

14.8.3. Malaysia Neurosurgery Market

14.8.3.1. Introduction

14.8.3.2. Market Analysis and Forecast by Market Taxonomy

14.8.3.2.1. By Product

14.8.3.2.2. By End User

14.8.4. Thailand Neurosurgery Market

14.8.4.1. Introduction

14.8.4.2. Market Analysis and Forecast by Market Taxonomy

14.8.4.2.1. By Product

14.8.4.2.2. By End User

15. East Asia Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

15.3.1. By Country

15.3.1.1. China

15.3.1.2. Japan

15.3.1.3. South Korea

15.3.2. By Product

15.3.3. By End User

15.4. Market Attractiveness Analysis

15.4.1. By Country

15.4.2. By Product

15.4.3. By End User

15.5. Market Trends

15.6. Key Market Participants - Intensity Mapping

15.7. Drivers and Restraints - Impact Analysis

15.8. Country Level Analysis & Forecast

15.8.1. China Neurosurgery Market

15.8.1.1. Introduction

15.8.1.2. Market Analysis and Forecast by Market Taxonomy

15.8.1.2.1. By Product

15.8.1.2.2. By End User

15.8.2. Japan Neurosurgery Market

15.8.2.1. Introduction

15.8.2.2. Market Analysis and Forecast by Market Taxonomy

15.8.2.2.1. By Product

15.8.2.2.2. By End User

15.8.3. South Korea Neurosurgery Market

15.8.3.1. Introduction

15.8.3.2. Market Analysis and Forecast by Market Taxonomy

15.8.3.2.1. By Product

15.8.3.2.2. By End User

16. Oceania Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

16.1. Introduction

16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

16.3.1. By Country

16.3.1.1. Australia

16.3.1.2. New Zealand

16.3.2. By Product

16.3.3. By End User

16.4. Market Attractiveness Analysis

16.4.1. By Country

16.4.2. By Product

16.4.3. By End User

16.5. Market Trends

16.6. Key Market Participants - Intensity Mapping

16.7. Drivers and Restraints - Impact Analysis

16.8. Country Level Analysis & Forecast

16.8.1. Australia Neurosurgery Market

16.8.1.1. Introduction

16.8.1.2. Market Analysis and Forecast by Market Taxonomy

16.8.1.2.1. By Product

16.8.1.2.2. By End User

16.8.2. New Zealand Neurosurgery Market

16.8.2.1. Introduction

16.8.2.2. Market Analysis and Forecast by Market Taxonomy

16.8.2.2.1. By Product

16.8.2.2.2. By End User

17. Middle East and Africa Neurosurgery Market Analysis 2017–2021 and Forecast 2022–2032

17.1. Introduction

17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2017–2021

17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

17.3.1. By Country

17.3.1.1. GCC Countries

17.3.1.2. Turkey

17.3.1.3. Israel

17.3.1.4. Northern Africa

17.3.1.5. South Africa

17.3.1.6. Rest of Middle East and Africa

17.3.2. By Product

17.3.3. By End User

17.4. Market Attractiveness Analysis

17.4.1. By Country

17.4.2. By Product

17.4.3. By End User

17.5. Market Trends

17.6. Key Market Participants - Intensity Mapping

17.7. Drivers and Restraints - Impact Analysis

17.8. Country Level Analysis & Forecast

17.8.1. GCC Countries Neurosurgery Market

17.8.1.1. Introduction

17.8.1.2. Market Analysis and Forecast by Market Taxonomy

17.8.1.2.1. By Product

17.8.1.2.2. By End User

17.8.2. Turkey Neurosurgery Market

17.8.2.1. Introduction

17.8.2.2. Market Analysis and Forecast by Market Taxonomy

17.8.2.2.1. By Product

17.8.2.2.2. By End User

17.8.3. North Africa Neurosurgery Market

17.8.3.1. Introduction

17.8.3.2. Market Analysis and Forecast by Market Taxonomy

17.8.3.2.1. By Product

17.8.3.2.2. By End User

17.8.4. South Africa Neurosurgery Market

17.8.4.1. Introduction

17.8.4.2. Market Analysis and Forecast by Market Taxonomy

17.8.4.2.1. By Product

17.8.4.2.2. By End User

18. Market Structure Analysis

18.1. Market Analysis by Tier of Companies

18.2. Market Share Analysis of Top Players

18.3. Market Presence Analysis

19. Competition Analysis

19.1. Competition Dashboard

19.2. Competition Benchmarking

19.3. Competition Deep Dive

19.3.1. Stryker Corp.

19.3.1.1. .Overview

19.3.1.2. Product Portfolio

19.3.1.3. Key Financials

19.3.1.4. SWOT Analysis

19.3.1.5. Key Developments

19.3.1.6. Sales Footprint

19.3.1.7. Strategy Overview

19.3.1.7.1. Marketing Strategy

19.3.1.7.2. Product Strategy

19.3.1.7.3. Channel Strategy

19.3.2. B. Braun Melsungen AG

19.3.2.1. Overview

19.3.2.2. Product Portfolio

19.3.2.3. Key Financials

19.3.2.4. SWOT Analysis

19.3.2.5. Key Developments

19.3.2.6. Sales Footprint

19.3.2.7. Strategy Overview

19.3.2.7.1. Marketing Strategy

19.3.2.7.2. Product Strategy

19.3.2.7.3. Channel Strategy

19.3.3. Medtronic plc

19.3.3.1. Overview

19.3.3.2. Product Portfolio

19.3.3.3. Key Financials

19.3.3.4. SWOT Analysis

19.3.3.5. Key Developments

19.3.3.6. Sales Footprint

19.3.3.7. Strategy Overview

19.3.3.7.1. Marketing Strategy

19.3.3.7.2. Product Strategy

19.3.3.7.3. Channel Strategy

19.3.4. DePuy Synthes

19.3.4.1. Overview

19.3.4.2. Product Portfolio

19.3.4.3. Key Financials

19.3.4.4. SWOT Analysis

19.3.4.5. Key Developments

19.3.4.6. Sales Footprint

19.3.4.7. Strategy Overview

19.3.4.7.1. Marketing Strategy

19.3.4.7.2. Product Strategy

19.3.4.7.3. Channel Strategy

19.3.5. Boston Scientific

19.3.5.1. Overview

19.3.5.2. Product Portfolio

19.3.5.3. Key Financials

19.3.5.4. SWOT Analysis

19.3.5.5. Key Developments

19.3.5.6. Sales Footprint

19.3.5.7. Strategy Overview

19.3.5.7.1. Marketing Strategy

19.3.5.7.2. Product Strategy

19.3.5.7.3. Channel Strategy

19.3.6. Terumo Corporation

19.3.6.1. Overview

19.3.6.2. Product Portfolio

19.3.6.3. Key Financials

19.3.6.4. SWOT Analysis

19.3.6.5. Key Developments

19.3.6.6. Sales Footprint

19.3.6.7. Strategy Overview

19.3.6.7.1. Marketing Strategy

19.3.6.7.2. Product Strategy

19.3.6.7.3. Channel Strategy

19.3.7. KARL STORZ GmbH & Co KG

19.3.7.1. Overview

19.3.7.2. Product Portfolio

19.3.7.3. Key Financials

19.3.7.4. SWOT Analysis

19.3.7.5. Key Developments

19.3.7.6. Sales Footprint

19.3.7.7. Strategy Overview

19.3.7.7.1. Marketing Strategy

19.3.7.7.2. Product Strategy

19.3.7.7.3. Channel Strategy

19.3.8. Integra LifeSciences

19.3.8.1. Overview

19.3.8.2. Product Portfolio

19.3.8.3. Key Financials

19.3.8.4. SWOT Analysis

19.3.8.5. Key Developments

19.3.8.6. Sales Footprint

19.3.8.7. Strategy Overview

19.3.8.7.1. Marketing Strategy

19.3.8.7.2. Product Strategy

19.3.8.7.3. Channel Strategy

19.3.9. Penumbra Inc

19.3.9.1. Overview

19.3.9.2. Product Portfolio

19.3.9.3. Key Financials

19.3.9.4. SWOT Analysis

19.3.9.5. Key Developments

19.3.9.6. Sales Footprint

19.3.9.7. Strategy Overview

19.3.9.7.1. Marketing Strategy

19.3.9.7.2. Product Strategy

19.3.9.7.3. Channel Strategy

19.3.10. Adeor Medical AG

19.3.10.1. Overview

19.3.10.2. Product Portfolio

19.3.10.3. Key Financials

19.3.10.4. SWOT Analysis

19.3.10.5. Key Developments

19.3.10.6. Sales Footprint

19.3.10.7. Strategy Overview

19.3.10.7.1. Marketing Strategy

19.3.10.7.2. Product Strategy

19.3.10.7.3. Channel Strategy

19.3.11. Elekta

19.3.11.1. Overview

19.3.11.2. Product Portfolio

19.3.11.3. Key Financials

19.3.11.4. SWOT Analysis

19.3.11.5. Key Developments

19.3.11.6. Sales Footprint

19.3.11.7. Strategy Overview

19.3.11.7.1. Marketing Strategy

19.3.11.7.2. Product Strategy

19.3.11.7.3. Channel Strategy

19.3.12. Clarus Medical

19.3.12.1. Overview

19.3.12.2. Product Portfolio

19.3.12.3. Key Financials

19.3.12.4. SWOT Analysis

19.3.12.5. Key Developments

19.3.12.6. Sales Footprint

19.3.12.7. Strategy Overview

19.3.12.7.1. Marketing Strategy

19.3.12.7.2. Product Strategy

19.3.12.7.3. Channel Strategy

19.3.13. MACHIDA ENDOSCOPE CO., LTD.

19.3.13.1. Overview

19.3.13.2. Product Portfolio

19.3.13.3. Key Financials

19.3.13.4. SWOT Analysis

19.3.13.5. Key Developments

19.3.13.6. Sales Footprint

19.3.13.7. Strategy Overview

19.3.13.7.1. Marketing Strategy

19.3.13.7.2. Product Strategy

19.3.13.7.3. Channel Strategy

20. Assumptions and Acronyms Used

21. Research Methodology

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

よくあるご質問


Persistence Market Research社はどのような調査会社ですか?


パーシスタンスマーケットリサーチ(Persistence Market Research/PMR)は独自の方法論を用いたデータ解析と市場調査をベースに広範な産業調査報告書とカスタム調査を提供しています... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/22 10:26

155.52 円

163.34 円

198.56 円

ページTOPに戻る